Immunisation Against Hepatitis B in BMT- and Leukemia-Patients

  • C. Rosendahl
  • Ch. Bender-Götze
  • F. Deinhardt
  • H.-J. Kolb
  • R. Haas
Part of the Experimental Hematology book series (HEMATOLOGY)

Abstract

Hepatitis B infections in immunocompromised leukemic children or in BM recipients mostly take an inapparent course. However, a considerable proportion of these patients become chronic carriers and one third is considered infectious (HBsAg and HBeAg positive). To prevent this carrier status most centers immunise their patients by administration of hepatitis B immunoglobulin (HBIG) which confers only incomplete protection.

Keywords

Hepatitis Leukemia Haas Vaccina Tion 

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • C. Rosendahl
    • 1
  • Ch. Bender-Götze
    • 1
  • F. Deinhardt
    • 2
  • H.-J. Kolb
    • 1
  • R. Haas
    • 1
  1. 1.Münchener Arbeitsgemeinschaft Knochenmark-TransplantationMünchenFederal Republic of Germany
  2. 2.Max-von-Pettenkofer-InstitutUniversität MünchenMünchenFederal Republic of Germany

Personalised recommendations